Top 10 Medical AI Stocks on Wall Street’s Radar

4. Tempus AI (NASDAQ:TEM)

Number of Hedge Fund Holders: 7

Tempus AI (NASDAQ:TEM) uses AI to extract insights from its mega repository of clinical and molecular data, with the goal of helping physicians make real-time, data-driven decisions. In turn, medical professionals are able to offer personalized care and targeted therapies via their ML platform. Its unparalleled platforms accelerate the discovery of novel targets, identify life-saving clinical trials, and help predict the effectiveness of treatments.

On January 14th, Loom Capital reduced the company’s target price to $52 from $57 while retaining a “Buy” rating. The brokerage argued that Tempus AI’s (NASDAQ:TEM) below-consensus Q4 revenue pre-announcement, though the deficit was potentially due to weakness in the company’s Compass Contract Research Organization division, which Loop Capital views as a non-core segment. Analysts added that Tempus AI (NASDAQ:TEM) also didn’t divulge formal profitability guidance, except a projected sequential growth in adjusted EBITDA in Q4.